Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinfang Biyan Capsule is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Chongqing Sainuo Biological Pharmaceutical. It is an oral capsule indicated for the treatment of various nasal conditions, including chronic rhinitis and sinusitis. The preparation is designed to dispel wind, clear heat, and ventilate the nasal passages, thereby alleviating symptoms such as nasal congestion, discharge, and inflammation. The formulation consists of a complex blend of herbal extracts, including *Flos Magnoliae* (Xin'yi), *Radix Angelicae Dahuricae* (Baizhi), and *Herba Asari* (Xixin), which are traditionally recognized for their ability to open the nasal orifices. Modern pharmacological studies on these constituent herbs suggest they exert therapeutic effects through anti-inflammatory and anti-allergic mechanisms, including the modulation of inflammatory mediators and histamine release.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xinfang biyan capsule.